DK567474A - - Google Patents

Info

Publication number
DK567474A
DK567474A DK567474A DK567474A DK567474A DK 567474 A DK567474 A DK 567474A DK 567474 A DK567474 A DK 567474A DK 567474 A DK567474 A DK 567474A DK 567474 A DK567474 A DK 567474A
Authority
DK
Denmark
Application number
DK567474A
Other languages
Danish (da)
Inventor
Z Prochazka
T Barth
J H Cort
K Jost
F Sorm
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of DK567474A publication Critical patent/DK567474A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/15Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK567474A 1973-11-09 1974-10-31 DK567474A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS7700A CS171787B1 (es) 1973-11-09 1973-11-09

Publications (1)

Publication Number Publication Date
DK567474A true DK567474A (es) 1975-07-07

Family

ID=5426587

Family Applications (1)

Application Number Title Priority Date Filing Date
DK567474A DK567474A (es) 1973-11-09 1974-10-31

Country Status (15)

Country Link
US (1) US3980631A (es)
JP (1) JPS5411319B2 (es)
AR (1) AR207765A1 (es)
BE (1) BE822062A (es)
CA (1) CA1020547A (es)
CH (1) CH610879A5 (es)
CS (1) CS171787B1 (es)
DE (1) DE2452279A1 (es)
DK (1) DK567474A (es)
FR (1) FR2250751B1 (es)
GB (1) GB1440859A (es)
IN (1) IN140167B (es)
IT (1) IT1056739B (es)
NL (1) NL7414490A (es)
SE (1) SE419753B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235881A (en) * 1978-12-04 1980-11-25 Cort Joseph H Method for producing high potency factor VIII
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4829051A (en) * 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4551445A (en) * 1983-10-14 1985-11-05 The Medical College Of Ohio Derivatives of arginine vasopressin antagonists
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
IE58407B1 (en) * 1984-04-13 1993-09-22 Akzo Nv Peptides
US4760052A (en) * 1986-01-16 1988-07-26 Smithkline Beckman Corporation 1,6-dicarba-vasopressin compounds
EP0300036A4 (en) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd PHARMACEUTICAL COMPOSITIONS BASED ON VASOPRESSIN.
US4786631A (en) * 1988-03-18 1988-11-22 University Of Florida Novel arginine vasopressin-binding peptides
US6028168A (en) 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
AU2237095A (en) * 1994-04-01 1995-10-23 Arcturus Pharmaceutical Corporation Method for delivering biologically active materials using a thioester or thioether prodrug
US5562812A (en) * 1995-04-03 1996-10-08 The Penn State Research Foundation Free flow electrophoresis device for biomolecule purification and separation in zero and one G
JP5731396B2 (ja) 2008-12-22 2015-06-10 アラガン,インコーポレイティド 鼻腔内デスモプレシン投与
US20100160214A1 (en) * 2008-12-22 2010-06-24 Serenity Pharmaceuticals Corporation Desmopressin composition
MX343193B (es) 2009-06-18 2016-10-26 Allergan Inc Administracion segura de desmopresina.

Also Published As

Publication number Publication date
BE822062A (fr) 1975-03-03
DE2452279A1 (de) 1975-05-15
CS171787B1 (es) 1976-11-29
NL7414490A (nl) 1975-05-13
IT1056739B (it) 1982-02-20
FR2250751B1 (es) 1979-05-11
SE7411817L (es) 1975-05-12
CH610879A5 (es) 1979-05-15
GB1440859A (en) 1976-06-30
JPS5411319B2 (es) 1979-05-14
SE419753B (sv) 1981-08-24
JPS5088085A (es) 1975-07-15
US3980631A (en) 1976-09-14
IN140167B (es) 1976-09-25
FR2250751A1 (es) 1975-06-06
CA1020547A (en) 1977-11-08
AR207765A1 (es) 1976-10-29

Similar Documents

Publication Publication Date Title
AR201758A1 (es)
AU476761B2 (es)
AU465372B2 (es)
AR201235Q (es)
AR201231Q (es)
AU474593B2 (es)
AU474511B2 (es)
AU474838B2 (es)
AU471343B2 (es)
JPS5411319B2 (es)
AU465453B2 (es)
AU465434B2 (es)
AU450229B2 (es)
AU476714B2 (es)
AR201229Q (es)
AU466283B2 (es)
AU476696B2 (es)
AU472848B2 (es)
AR199451A1 (es)
AU477823B2 (es)
AR197627A1 (es)
AR195948A1 (es)
AR200256A1 (es)
AR201432A1 (es)
AR200885A1 (es)